Article metrics

Download PDFPDF

474 Phase 1 study of SEA-TGT, a human, nonfucosylated anti-TIGIT monoclonal antibody with enhanced immune-effector function, in patients with advanced malignancies (SGNTGT-001, trial in progress)
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to January 2024

AbstractFullPdf
Nov 2021423018
Dec 2021128014
Jan 202213606
Feb 202278011
Mar 2022232015
Apr 202213009
May 2022132017
Jun 2022160014
Jul 202211407
Aug 2022158017
Sep 2022166021
Oct 2022186014
Nov 202211807
Dec 202210207
Jan 20239806
Feb 2023128016
Mar 202313808
Apr 202398012
May 202382011
Jun 20233802
Jul 202368017
Aug 202382014
Sep 20235807
Oct 202392020
Nov 20237006
Dec 20237005
Jan 20244003
Total33250304